Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;28:622-626

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harrap, S. B.
Right arrow Articles by O'Sullivan, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrap, S. B.
Right arrow Articles by O'Sullivan, J. B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Transplantation
*High Blood Pressure

(Hypertension. 1996;28:622-626.)
© 1996 American Heart Association, Inc.


Articles

Cardiac Transplantation, Perindopril, and Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats

Stephen B. Harrap; Joseph B. O'Sullivan

the Genetic Physiology Unit, Department of Medicine, University of Melbourne (Victoria, Australia), Austin Hospital.

Angiotensin-converting enzyme inhibitors reduce blood pressure and cardiac mass but may also have a direct effect on myocardial growth. To test this hypothesis, we studied the effects of perindopril on the weight of transplanted hearts in which the left ventricle does not pump blood. Hearts were transplanted between littermate 10-week-old male spontaneously hypertensive rats, and recipients were treated for 2 weeks with vehicle (n=10), perindopril (3 mg/kg per day) (n=9), perindopril (3 mg/kg per day) plus the selective bradykinin B2 receptor antagonist Hoe 140 (500 µg/kg per day) (n=13), or angiotensin II (200 ng/kg per minute) (n=12). Perindopril reduced blood pressure and native left ventricular weight and also caused a significant decrease in the weight of the transplanted left ventricle compared with controls. Hoe 140 did not significantly alter blood pressure or native left ventricular weight of perindopril-treated rats but caused a significant increase in the weight of the transplanted left ventricle compared with rats treated with perindopril alone. Angiotensin treatment resulted in a significant increase in blood pressure and native left ventricular weight but no significant change in the weight of the transplanted left ventricle. Blood pressure and left ventricular weight for native but not for transplanted hearts were positively correlated. Therefore, in the absence of mechanical load, the weight of the left ventricle of spontaneously hypertensive rats responds little to angiotensin II but can be reduced by angiotensin-converting enzyme inhibition. The effect of perindopril on transplanted hearts of spontaneously hypertensive rats appears to depend on bradykinin.


Key Words: angiotensin • bradykinin • hypertension, genetic • hypertrophy • transplantation




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. Goland, L. S.C. Czer, R. M. Kass, R. J. Siegel, J. Mirocha, M. A. De Robertis, J. Lee, S. Raissi, W. Cheng, G. Fontana, et al.
Use of Cardiac Allografts With Mild and Moderate Left Ventricular Hypertrophy Can Be Safely Used in Heart Transplantation to Expand the Donor Pool
J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1214 - 1220.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Higaki, M. Aoki, R. Morishita, I. Kida, Y. Taniyama, N. Tomita, K. Yamamoto, A. Moriguchi, Y. Kaneda, and T. Ogihara
In Vivo Evidence of the Importance of Cardiac Angiotensin-Converting Enzyme in the Pathogenesis of Cardiac Hypertrophy
Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 428 - 434.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P.A. van Zwieten
The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy
Cardiovasc Res, January 1, 2000; 45(1): 82 - 91.
[Abstract] [Full Text] [PDF]